STERIS’ (TSE:STE – Get Free Report) was upgraded by equities research analysts at Atb Cap Markets to a “strong-buy” rating in a research note issued on Sunday,Zacks.com reports.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- How to Use the MarketBeat Dividend Calculator
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Pros And Cons Of Monthly Dividend Stocks
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- EV Stocks and How to Profit from Them
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
